T. Rowe Price Associates’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68K | Hold |
|
|||||
|
2025
Q1 | $58K | Buy |
|
|||||
|
2024
Q4 | $59K | Buy |
|
|||||
|
2024
Q3 | $35K | Hold |
|
|||||
|
2024
Q2 | $0 | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $108K | Hold |
|
|||||
|
2022
Q2 | $129K | Sell |
|
|||||
|
2022
Q1 | $139K | Buy |
|
|||||
|
2021
Q4 | $44K | Sell |
|
|||||
|
2021
Q3 | $103K | Hold |
|
|||||
|
2021
Q2 | $135K | Buy |
|
|||||
|
2021
Q1 | $136K | Sell |
|
|||||
|
2020
Q4 | $144K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $9.44M | Sell |
|
|||||
|
2020
Q1 | $8.74M | Buy |
|
|||||
|
2019
Q4 | $6M | Buy |
|
|||||
|
2019
Q3 | $6.24M | Buy |
|
|||||
|
2019
Q2 | $6.34M | Sell |
|
|||||
|
2019
Q1 | $30.5M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $252K | Buy |
|
|||||
|
2018
Q1 | $284K | Sell |
|
|||||
|
2017
Q4 | $195M | Sell |
|
|||||
|
2017
Q3 | $629M | Buy |
|
|||||
|
2017
Q2 | $300M | Buy |
|
|||||
|
2017
Q1 | $42.7M | Buy |
|
|||||
|
2016
Q4 | $20.8M | Sell |
|
|||||
|
2016
Q3 | $62.5M | Sell |
|
|||||
|
2016
Q2 | $30.3M | Sell |
|
|||||
|
2016
Q1 | $50.1M | Sell |
|
|||||
|
2015
Q4 | $135M | Sell |
|
|||||
|
2015
Q3 | $130M | Sell |
|
|||||
|
2015
Q2 | $245M | Sell |
|
|||||
|
2015
Q1 | $708M | Buy |
|
|||||
|
2014
Q4 | $524M | Sell |
|
|||||
|
2014
Q3 | $844M | Buy |
|
|||||
|
2014
Q2 | $212M | Buy |
|
|||||
|
2014
Q1 | $308M | Buy |
|
|||||
|
2013
Q4 | $305M | Buy |
|
|||||
|
2013
Q3 | $72.7M | Sell |
|
|||||
|
2013
Q2 | $61.2M | Buy |
|